Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Gregory Casciaro
AddedMar 31, 2024
UpdatedMay 31, 2026
Gregory Casciaro

Gregory Casciaro

Board Member, Tulavi Therapeutics

CrunchbaseLinkedIn

Gregory Casciaro's Career

Tulavi Therapeutics
Tulavi Therapeutics

Mountain View, CA, US

Board Member· Board
Foldax
Foldax

Salt Lake City, UT, US

CEO· C-Suite · Management
Trireme Medical
Trireme Medical

Pleasanton, CA, US

Board Member· Board
Cardiac Dimensions
Cardiac Dimensions

Kirkland, WA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Gregory Casciaro's Career

Tulavi Therapeutics
Tulavi Therapeutics
Pre-Seed$5.8M202018Mountain View, CA, US
Board Member· Board

Leadership at Tulavi Therapeutics

Fred KhosraviFred KhosraviBoard Member
Henry ChenHenry ChenCo-Founder
Corinne BrightCorinne BrightCo-Founder

Similar to Tulavi Therapeutics

Neuraptive TherapeuticsNeuraptive TherapeuticsLafayette, CO, USMedical Devicesest. 2016Neuraptive TherapeuticsLafayette, CO, US · est. 2016

Neuraptive Therapeutics: A US-based med-tech firm specializing in therapeutic solutions for nerve injuries.

Series A · $20M18
ThermaquilThermaquilPhiladelphia, PA, USMedical Devicesest. 2017ThermaquilPhiladelphia, PA, US · est. 2017

Thermaquil: Innovating drug-free, reversible nerve block devices for effective pain management.

Pre-Seed · $1.2M2
RenervaRenervaPittsburgh, PA, USMedical Devicesest. 2017RenervaPittsburgh, PA, US · est. 2017

Renerva: Innovating implantable tech for enhanced peripheral nerve repair outcomes.

Pre-Seed · $4.2M9
Latigo BiotherapeuticsLatigo BiotherapeuticsThousand Oaks, CA, USDrug Developmentest. 2018Latigo BiotherapeuticsThousand Oaks, CA, US · est. 2018

Non-opioid drug developer providing unique therapies for chronic pain without addiction risks.

Series B · $15M18
Foldax
Foldax
Series A$43.4M402013Salt Lake City, UT, US
CEO· C-Suite · Management

Leadership at Foldax

Scott HuennekensScott HuennekensBoard Member
Ken CharhutKen CharhutBoard Member
Jim DemetriadesJim DemetriadesBoard Member
Brant HeiseBrant HeiseBoard Member
Frank MaguireFrank MaguireFounder
Trireme Medical
Trireme Medical
Public$58.9M752005Pleasanton, CA, US
Board Member· Board

Leadership at Trireme Medical

Heng Tong ChooHeng Tong ChooBoard Member
Amir BelsonAmir BelsonBoard Member
Momi Brosh MimonMomi Brosh MimonCEO
Eitan KonstantinoEitan KonstantinoBoard Member

Similar to Trireme Medical

Concept MedicalConcept MedicalTampa, FL, USMedical Devicesest. 2008Concept MedicalTampa, FL, US · est. 2008

Concept Medical: Innovating treatments for coronary and peripheral artery diseases with advanced medical devices.

Series D · $60M234
Tri-MedicsTri-MedicsWalpole, MA, USMedical Instruments, Surgical Instrumentsest. 2000Tri-MedicsWalpole, MA, US · est. 2000

Tri-Medics, LLC: Designing, manufacturing, and distributing advanced medical and surgical instruments since 2000.

Angel · $160k7
Triage MedicalTriage MedicalIrvine, CA, USest. 2000Triage MedicalIrvine, CA, US · est. 2000

Innovative orthopedic trauma device manufacturer in Irvine, CA.

Series B · $10M50
Triaxis Medical DevicesTriaxis Medical DevicesSan Leandro, CA, USHealthcare Supplies, Medical Devicesest. 2008Triaxis Medical DevicesSan Leandro, CA, US · est. 2008

Triaxis Medical Devices: A leading healthcare supply company based in San Leandro, California.

Seed · $150k30
Cardiac Dimensions
Cardiac Dimensions
Public$209.7M622001Kirkland, WA, US
Board Member· Board

Leadership at Cardiac Dimensions

Gerry BrunkGerry BrunkBoard Member
Jan GarfinkleJan GarfinkleBoard Member
Nathan EveryNathan EveryBoard Member
Trevor MoodyTrevor MoodyBoard Member
Renee RyanRenee RyanBoard Member
Mark MathisMark MathisFounder

Gregory Casciaro's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Gregory Casciaro

Will ReevesWill ReevesCEO · FoldAndrew ArrudaAndrew ArrudaFounder & CEO · Automate MedicalEric Reithler-BarrosEric Reithler-BarrosCo-Founder · RcrdshpGreg GalvinGreg GalvinCEO · MezmerizJeff McLarenJeff McLarenBoard Member · HealthStreamSal BraicoSal BraicoBoard Member · Flex Biomedical